Fidelity National Information Servcs Inc (FIS) Stock Price Today
Aura AI Summary
Key Stats
- $21.66BMarket Cap
- -Volume
- TechnologySector
- $81.9452W High
- $37.7252W Low
- -Typical Hold Time
- $42.05BEnterprise Value
- 4.01%Div Yield
- -Trading Activity
Track Fidelity National Information Servcs Inc (FIS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Fidelity National Information Servcs Inc has traded between a low of $37.72 and a high of $81.94, highlighting its annual price range. Buy and sell Fidelity National Information Servcs Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Most Recent News
Target launches exclusive baby collection and gets a 'Buy' rating with a $150 price target.
Target is launching "Picolette," an exclusive baby collection by Olivia Culpo, featuring 60 stylish and affordable items to boost its baby product segment. The collection will be available in about 1,400 stores and online starting July 26, enhancing ...

Needham downgrades Personalis to Hold after $1.5B Tempus AI acquisition deal announced
Personalis, a cancer testing firm, is being acquired by Tempus AI in a $1.5 billion all-stock deal offering $16.25 per share, a 28% premium. Despite the premium, Personalis shares dropped 13.39% on the announcement day due to capped upside until deal...

Global antiparasitic drugs market to grow to $31B by 2032 amid rising resistance and AI-driven innovation
The global antiparasitic drugs market is projected to grow from $23.3 billion in 2026 to $30.98 billion by 2032, driven by persistent parasitic diseases, drug resistance, and climate change. Innovations focus on resistance-ready therapies, pediatric ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.